ADMA Biologics, Inc. (ADMA)
16.43
+0.49
(+3.07%)
USD |
NASDAQ |
Feb 06, 16:00
16.42
-0.01
(-0.06%)
After-Hours: 20:00
ADMA Biologics EPS Diluted (Quarterly) : 0.1489 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 0.0558 |
| Marker Therapeutics, Inc. | -0.1193 |
| CorMedix, Inc. | 1.259 |
| Editas Medicine, Inc. | -0.2788 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 36.43M |
| Revenue (Quarterly) | 134.22M |
| Total Expenses (Quarterly) | 97.80M |
| Enterprise Value | 3.932B |
| Gross Profit Margin (Quarterly) | 56.31% |
| Profit Margin (Quarterly) | 27.14% |
| Earnings Yield | 5.18% |
| Operating Earnings Yield | 4.13% |
| Normalized Earnings Yield | 5.262 |